The Effect of Debulking Surgery after Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian Cancer

M. van Lent, Marc Buyse, A Kobierska, +6

New England Journal of Medicine

The Effect of Debulking Surgery After Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian Cancer

Maria E.L. van der Burg, M. van Lent, Marc Buyse, +7

Obstetrical & Gynecological Survey

Translation StudiesSurgical OncologyFrenchSpanish LiteratureCancer Management +23

Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study

Scott M. Eisenkop, Nick M. Spirtos, Richard L. Friedman, +3

Gynecologic Oncology

Surgical OncologyGynecological SurgeryAdvanced Ovarian CancerMedicineRelative Influences +7

Secondary Surgical Cytoreduction for Advanced Ovarian Carcinoma

Peter G. Rose, Stacy Nerenstone, Mark F. Brady, +5

New England Journal of Medicine

Neoadjuvant Chemotherapy or Primary Debulking Surgery in Advanced Ovarian Carcinoma: A Retrospective Analysis of 285 Patients

Ignace Vergote, Ivo De Wever, Wiebren Tjalma, +3

Gynecologic Oncology

Gynecologic SurgerySurgical OncologyGynecological SurgeryNeoadjuvant ChemotherapyMedicine +8

Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach

S. Dennis, Corinna C. Franklin, Douglas A. Levine, +7

Gynecologic Oncology

Surgical OncologyGynecological SurgeryMedicineGynecologyFallopian Tube +7

Multi-Institutional Reciprocal Validation Study of Computed Tomography Predictors of Suboptimal Primary Cytoreduction in Patients With Advanced Ovarian Cancer

Allison E. Axtell, Margaret H. Lee, Robert E. Bristow, +11

Journal of Clinical Oncology

Does Aggressive Surgery Only Benefit Patients With Less Advanced Ovarian Cancer? Results From an International Comparison Within the SCOTROC-1 Trial

Simon C. Crawford, P. Vasey, A. Hay, +2

Journal of Clinical Oncology

Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)

Pauline Wimberger, Nils Lehmann, Rainer Kimmig, +3

Gynecologic Oncology

Prognostic FactorsPrognostic EvaluationAdvanced Ovarian CancerMedicinePrognosis +7

Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease☆

Jinlin Hou, Martina Kelly, Hon J. Yu, +4

Gynecologic Oncology

Surgical OncologyGynecological SurgeryNeoadjuvant ChemotherapyAdvanced Ovarian CancerMedicine +8